The impact of artificial intelligence on a multi-omics approach toward predictive biomarkers for non-small cell lung cancer
Over the last four decades, lung cancer has been the leading cause of death in the United States. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and historically, treatment consists of surgical resection, chemotherapy, and/or radiotherapy. Over the past decade, targeted i...
Saved in:
| Main Authors: | Brandon Wilkins, Emily Hartman, Blake Kelley, Pranali Pachika, Joshua Bradley, James Bradley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-06-01
|
| Series: | Exploration of Digital Health Technologies |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A101153/101153.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real‐World Treatment Patterns and Associated Outcomes in Patients With Resectable Early‐Stage Non‐Small Cell Lung Cancer: The THASSOS International Study
by: Kumar Prabhash, et al.
Published: (2025-04-01) -
Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response
by: Iris van 't Erve, PhD, et al.
Published: (2025-09-01) -
Correlation of heat shock protein 1 expression with progression and prognosis of non-small cell lung cancer
by: Rui Wang, et al.
Published: (2025-05-01) -
Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors
by: Luigi Liguori, et al.
Published: (2025-08-01) -
Clinical Outcomes of Crizotinib Readministration in Patients with Nonsmall Cell Lung Cancer with Anaplastic Lymphoma Kinase Rearrangement: Case Report and Review of Literature
by: Prasant Kumar Parida